SAINT Therapy
Major Depressive Disorder (MDD), particularly treatment-resistant
ApprovedActive
Key Facts
Indication
Major Depressive Disorder (MDD), particularly treatment-resistant
Phase
Approved
Status
Active
Company
About Magnus Medical
Magnus Medical is a private, commercial-stage medical device company that has brought a novel, accelerated form of Transcranial Magnetic Stimulation (TMS) to market. Its SAINT Therapy combines personalized fMRI brain mapping with a proprietary targeting algorithm to deliver high-dose TMS over five days, achieving rapid remission for patients with treatment-resistant depression. The company holds FDA 510(k) clearance and Breakthrough Device Designation, positioning it to disrupt the standard of care for depression treatment.
View full company profile